The pharmaceutical industry is continuously evolving, with increasing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, stands as copyrightple of this trend. To fulfill this demand, US-based manufacturing services are stepping forward. These organizations